| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Suzana Meira Ribeiro | Q95948222 |
| Octávio Luiz Franco | Q55807541 | ||
| Marlon Henrique Cardoso | Q56013894 | ||
| P2093 | author name string | Osmel Fleitas Martínez | |
| P2860 | cites work | Flotillins functionally organize the bacterial membrane | Q46686821 |
| The LuxR receptor: the sites of interaction with quorum-sensing signals and inhibitors. | Q46792470 | ||
| Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis | Q46920622 | ||
| aBiofilm: a resource of anti-biofilm agents and their potential implications in targeting antibiotic drug resistance | Q47100874 | ||
| Kaempferol Inhibits the Primary Attachment Phase of Biofilm Formation in Staphylococcus aureus | Q47117443 | ||
| Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus. | Q47119712 | ||
| Membrane Microdomain Disassembly Inhibits MRSA Antibiotic Resistance. | Q47123550 | ||
| Flotillin scaffold activity contributes to type VII secretion system assembly in Staphylococcus aureus | Q47139134 | ||
| Statins: antimicrobial resistance breakers or makers? | Q47140385 | ||
| Neutralizing α-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice. | Q47193259 | ||
| Combination Therapy Strategy of Quorum Quenching Enzyme and Quorum Sensing Inhibitor in Suppressing Multiple Quorum Sensing Pathways of P. aeruginosa. | Q47559168 | ||
| In Silico and in Vitro-Guided Identification of Inhibitors of Alkylquinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa | Q47704103 | ||
| Inhibition of quorum sensing related virulence factors of Pseudomonas aeruginosa by pyridoxal lactohydrazone | Q47759504 | ||
| Enzyme targets for drug design of new anti-virulence therapeutics | Q91485682 | ||
| Quorum sensing inhibitors as antipathogens: biotechnological applications | Q93339759 | ||
| Inhibition of alpha-hemolysin expression by resveratrol attenuates Staphylococcus aureus virulence | Q93369994 | ||
| Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance | Q21089631 | ||
| Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent | Q24613185 | ||
| Mechanism of action and inhibition of dehydrosqualene synthase | Q24628816 | ||
| Dispersing biofilms with engineered enzymatic bacteriophage | Q24684087 | ||
| Beyond killing: Can we find new ways to manage infection? | Q26750724 | ||
| Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy | Q26752975 | ||
| PqsBC, a Condensing Enzyme in the Biosynthesis of thePseudomonas aeruginosaQuinolone Signal | Q27312117 | ||
| Structural mechanism for statin inhibition of HMG-CoA reductase | Q27631717 | ||
| Crystal structure of a statin bound to a class II hydroxymethylglutaryl-CoA reductase | Q27640636 | ||
| Transition state analogs of 5'-methylthioadenosine nucleosidase disrupt quorum sensing | Q27654037 | ||
| The SaeRS Two-Component System of Staphylococcus aureus | Q28073824 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia | Q28260215 | ||
| Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa | Q28473858 | ||
| The Campylobacter jejuni Cj0268c protein is required for adhesion and invasion in vitro | Q28484956 | ||
| Structure-Based Design and Biological Evaluation of Triphenyl Scaffold-Based Hybrid Compounds as Hydrolytically Stable Modulators of a LuxR-Type Quorum Sensing Receptor | Q36454100 | ||
| The role of 2,4-dihydroxyquinoline (DHQ) in Pseudomonas aeruginosa pathogenicity | Q36469527 | ||
| A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions | Q36483482 | ||
| Auto Poisoning of the Respiratory Chain by a Quorum-Sensing-Regulated Molecule Favors Biofilm Formation and Antibiotic Tolerance | Q36510450 | ||
| Exploration of Modulated Genetic Circuits Governing Virulence Determinants in Staphylococcus aureus | Q36510788 | ||
| The quorum quenching antibody RS2-1G9 protects macrophages from the cytotoxic effects of the Pseudomonas aeruginosa quorum sensing signalling molecule N-3-oxo-dodecanoyl-homoserine lactone | Q36608383 | ||
| Exploiting quorum sensing to confuse bacterial pathogens | Q36667376 | ||
| Targeting virulence: a new paradigm for antimicrobial therapy | Q36914994 | ||
| Bacterial strategies of resistance to antimicrobial peptides. | Q36920921 | ||
| Host-pathogen interactions in sepsis | Q37026360 | ||
| Efficacy of AiiM, an N-acylhomoserine lactonase, against Pseudomonas aeruginosa in a mouse model of acute pneumonia | Q37036592 | ||
| What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention | Q37066508 | ||
| Highly Stable, Amide-Bridged Autoinducing Peptide Analogues that Strongly Inhibit the AgrC Quorum Sensing Receptor in Staphylococcus aureus | Q37149488 | ||
| Is Quorum Sensing Interference a Viable Alternative to Treat Pseudomonas aeruginosa Infections? | Q37254245 | ||
| Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections | Q37287845 | ||
| Quorum sensing signal-response systems in Gram-negative bacteria | Q37324474 | ||
| The end of an old hypothesis: the pseudomonas signaling molecules 4-hydroxy-2-alkylquinolines derive from fatty acids, not 3-ketofatty acids | Q37424462 | ||
| Retrocyclins neutralize bacterial toxins by potentiating their unfolding | Q37545884 | ||
| Effect of Quorum Quenching Lactonase in Clinical Isolates of Pseudomonas aeruginosa and Comparison with Quorum Sensing Inhibitors. | Q37639329 | ||
| Anti-virulence strategies to combat bacteria-mediated disease | Q37676924 | ||
| The biofilm formation defect of a Bacillus subtilis flotillin-defective mutant involves the protease FtsH. | Q37705575 | ||
| Mechanisms and synthetic modulators of AHL-dependent gene regulation | Q37818125 | ||
| Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles | Q37921384 | ||
| Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung | Q37981915 | ||
| Lipopolysaccharide neutralization by antimicrobial peptides: a gambit in the innate host defense strategy. | Q37996318 | ||
| Isoprenoid biosynthesis in bacterial pathogens | Q37998851 | ||
| AI-2-mediated signalling in bacteria | Q38019983 | ||
| Metabolic plasticity for isoprenoid biosynthesis in bacteria | Q38101378 | ||
| The increasingly complex mechanism of HMG-CoA reductase. | Q38125222 | ||
| Quorum quenching enzymes. | Q38249028 | ||
| Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. | Q38273318 | ||
| Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections. | Q38364049 | ||
| Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides | Q38519180 | ||
| Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response | Q38576398 | ||
| Quorum quenching: role in nature and applied developments | Q38598251 | ||
| Potential Emergence of Multi-quorum Sensing Inhibitor Resistant (MQSIR) Bacteria | Q38722412 | ||
| Dracorhodin Perochlorate attenuates Staphylococcus aureus USA300 virulence by decreasing α-toxin expression | Q38728314 | ||
| Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria | Q38736102 | ||
| New frontiers for anti-biofilm drug development | Q38741798 | ||
| Anti-virulence Strategies to Target Bacterial Infections | Q38760476 | ||
| Pseudomonas aeruginosa LasR·DNA Binding Is Directly Inhibited by Quorum Sensing Antagonists. | Q38771960 | ||
| Inhibition of quorum sensing-controlled biofilm formation in Pseudomonas aeruginosa by quorum-sensing inhibitors. | Q47939062 | ||
| Protein-mediated anti-adhesion surface against oral bacteria. | Q48161585 | ||
| Quorum-Sensing Systems as Targets for Antivirulence Therapy | Q49046920 | ||
| Hygrocin C from marine-derived Streptomyces sp. SCSGAA 0027 inhibits biofilm formation in Bacillus amyloliquefaciens SCSGAB0082 isolated from South China Sea gorgonian | Q49490835 | ||
| Synthesis, quorum sensing inhibition and docking studies of 1,5-dihydropyrrol-2-ones. | Q50278615 | ||
| Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide. | Q50676762 | ||
| Head-to-Head Prenyl Synthases in Pathogenic Bacteria. | Q50946882 | ||
| Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluation. | Q51274904 | ||
| Molecular Docking, Molecular Dynamics Simulations, Computational Screening to Design Quorum Sensing Inhibitors Targeting LuxP of Vibrio harveyi and Its Biological Evaluation. | Q51565431 | ||
| Eriodictyol protects against Staphylococcus aureus-induced lung cell injury by inhibiting alpha-hemolysin expression. | Q52578765 | ||
| A Biofilm Matrix-Associated Protease Inhibitor Protects Pseudomonas aeruginosa from Proteolytic Attack. | Q52595428 | ||
| Exploring the impact of parthenolide as anti-quorum sensing and anti-biofilm agent against Pseudomonas aeruginosa. | Q52663191 | ||
| Linear peptidomimetics as potent antagonists of Staphylococcus aureus agr quorum sensing. | Q52687686 | ||
| Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform. | Q52719970 | ||
| 5-Benzylidene-4-oxazolidinones potently inhibit biofilm formation in Methicillin-resistant Staphylococcus aureus. | Q53272194 | ||
| Coumarins reduce biofilm formation and the virulence of Escherichia coli O157:H7. | Q53549286 | ||
| Development of molecularly imprinted polymers to block quorum sensing and inhibit bacterial biofilm formation. | Q53681307 | ||
| PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection. | Q54213053 | ||
| Quorum Sensing-Regulated Phenol-Soluble Modulins Limit Persister Cell Populations in Staphylococcus aureus. | Q54260303 | ||
| Designer cells programming quorum-sensing interference with microbes. | Q54936236 | ||
| Terrein is an inhibitor of quorum sensing and c-di-GMP in Pseudomonas aeruginosa: a connection between quorum sensing and c-di-GMP. | Q55265092 | ||
| A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile. | Q55333418 | ||
| Characterization of AiiK, an AHL lactonase, from Kurthia huakui LAM0618T and its application in quorum quenching on Pseudomonas aeruginosa PAO1. | Q55354038 | ||
| In Vitro and In Vivo Activity of Peptidomimetic Compounds That Target the Periodontal Pathogen Porphyromonas gingivalis. | Q55426263 | ||
| Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against Gram-positive pathogens | Q57062562 | ||
| 2-Aminobenzimidazoles as antibiofilm agents against serovar Typhimurium | Q57136045 | ||
| Catechin-mediated restructuring of a bacterial toxin inhibits activity | Q57813110 | ||
| Targeting the quinolone signal quorum sensing system for the discovery of novel anti-infective pathoblockers | Q58560779 | ||
| Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) in reducing the motility and the biofilm formation of uropathogenic Escherichia coli | Q58715270 | ||
| Coumarin Reduces Virulence and Biofilm Formation in by Affecting Quorum Sensing, Type III Secretion and C-di-GMP Levels | Q58729430 | ||
| Identification of a Small Molecule Anti-biofilm Agent Against | Q59791673 | ||
| Lactam hybrid analogues of solonamide B and autoinducing peptides as potent S. aureus AgrC antagonists | Q62368197 | ||
| Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease | Q62368248 | ||
| Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5. | Q64965279 | ||
| Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis | Q74153291 | ||
| Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora | Q83186450 | ||
| Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae | Q84059475 | ||
| Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections | Q87398209 | ||
| Receptor-Based Peptides for Inhibition of Leukotoxin Activity | Q88615459 | ||
| Oral Biofilm Formation on Different Materials for Dental Implants | Q89472195 | ||
| α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis | Q90392500 | ||
| Impact of endotracheal tube biofilm and respiratory secretions on airway resistance and mechanics of breathing in a neonatal lung model | Q90495264 | ||
| Structural and Biochemical Characterization of AaL, a Quorum Quenching Lactonase with Unusual Kinetic Properties | Q90523757 | ||
| Subinhibitory concentrations of resveratrol reduce alpha-hemolysin production in Staphylococcus aureus isolates by downregulating saeRS | Q90672889 | ||
| Subinhibitory Concentrations of Prim-O-Glucosylcimifugin Decrease the Expression of Alpha-Hemolysin in Staphylococcus aureus (USA300) | Q90930842 | ||
| Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa. | Q45970428 | ||
| Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship. | Q46242750 | ||
| An Update on the Sociomicrobiology of Quorum Sensing in Gram-Negative Biofilm Development | Q46275919 | ||
| Mechanistic understanding of Phenyllactic acid mediated inhibition of quorum sensing and biofilm development in Pseudomonas aeruginosa | Q46293335 | ||
| Flavonoids Suppress Pseudomonas aeruginosa Virulence through Allosteric Inhibition of Quorum-sensing Receptors. | Q46428179 | ||
| Quorum-Quenching and Matrix-Degrading Enzymes in Multilayer Coatings Synergistically Prevent Bacterial Biofilm Formation on Urinary Catheters | Q46635815 | ||
| NMR structures and interactions of temporin-1Tl and temporin-1Tb with lipopolysaccharide micelles: mechanistic insights into outer membrane permeabilization and synergistic activity | Q35085167 | ||
| Cultivation-independent examination of horizontal transfer and host range of an IncP-1 plasmid among gram-positive and gram-negative bacteria indigenous to the barley rhizosphere | Q35091869 | ||
| Impact of Campylobacter jejuni cj0268c knockout mutation on intestinal colonization, translocation, and induction of immunopathology in gnotobiotic IL-10 deficient mice | Q35108746 | ||
| Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease | Q35111115 | ||
| Exfoliative toxins of Staphylococcus aureus | Q35155819 | ||
| ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. | Q35169008 | ||
| Small molecule disruption of quorum sensing cross-regulation in pseudomonas aeruginosa causes major and unexpected alterations to virulence phenotypes | Q35215393 | ||
| Inhibition of Salmonella enterica biofilm formation using small-molecule adenosine mimetics | Q35329761 | ||
| Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody | Q35530119 | ||
| Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damage | Q35548934 | ||
| Exploring the existence of lipid rafts in bacteria | Q35555348 | ||
| The role of innate immunity in promoting SaeR/S-mediated virulence in Staphylococcus aureus. | Q35619910 | ||
| Quorum quenching quandary: resistance to antivirulence compounds | Q35758927 | ||
| The Small Molecule DAM Inhibitor, Pyrimidinedione, Disrupts Streptococcus pneumoniae Biofilm Growth In Vitro | Q35797408 | ||
| Potent and Selective Modulation of the RhlR Quorum Sensing Receptor by Using Non-native Ligands: An Emerging Target for Virulence Control in Pseudomonas aeruginosa | Q35804360 | ||
| Campylobacter jejuni biofilms contain extracellular DNA and are sensitive to DNase I treatment | Q35837269 | ||
| Ultrashort Antimicrobial Peptides with Antiendotoxin Properties | Q35860048 | ||
| Fine-Tuning Covalent Inhibition of Bacterial Quorum Sensing. | Q35913305 | ||
| Engineered nanoparticles mimicking cell membranes for toxin neutralization | Q35991625 | ||
| Evaluation of ethyl N-(2-phenethyl) carbamate analogues as biofilm inhibitors of methicillin resistant Staphylococcus aureus | Q36061148 | ||
| Strain-specific transfer of antibiotic resistance from an environmental plasmid to foodborne pathogens | Q36082888 | ||
| Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. | Q36088381 | ||
| Biofilms: an emergent form of bacterial life | Q36100732 | ||
| Designed Small-Molecule Inhibitors of the Anthranilyl-CoA Synthetase PqsA Block Quinolone Biosynthesis in Pseudomonas aeruginosa | Q36141081 | ||
| Infection control by antibody disruption of bacterial quorum sensing signaling | Q36162145 | ||
| A new small molecule inhibits Streptococcus mutans biofilms in vitro and in vivo | Q36249980 | ||
| Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis | Q36274821 | ||
| Dual coenzyme specificity of Archaeoglobus fulgidus HMG-CoA reductase | Q36282074 | ||
| Exploring functional membrane microdomains in bacteria: an overview | Q36290863 | ||
| Reducing Virulence and Biofilm of Pseudomonas aeruginosa by Potential Quorum Sensing Inhibitor Carotenoid: Zeaxanthin. | Q36296165 | ||
| Mechanistic analysis of a synthetic inhibitor of the Pseudomonas aeruginosa LasI quorum-sensing signal synthase. | Q36305679 | ||
| Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme | Q36318434 | ||
| Targeting of Streptococcus mutans Biofilms by a Novel Small Molecule Prevents Dental Caries and Preserves the Oral Microbiome. | Q36389955 | ||
| A quorum sensing small volatile molecule promotes antibiotic tolerance in bacteria | Q28537801 | ||
| Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance | Q28539668 | ||
| Unravelling the Structural and Molecular Basis Responsible for the Anti-Biofilm Activity of Zosteric Acid | Q28545999 | ||
| The agr Inhibitors Solonamide B and Analogues Alter Immune Responses to Staphylococccus aureus but Do Not Exhibit Adverse Effects on Immune Cell Functions | Q28552024 | ||
| Structure-Function Analyses of a Staphylococcus epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC-type Receptor Modulation | Q28830075 | ||
| Quorum sensing: cell-to-cell communication in bacteria | Q29547325 | ||
| Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. | Q30584946 | ||
| Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors | Q31093948 | ||
| Inhibitors of pathogen intercellular signals as selective anti-infective compounds | Q33302936 | ||
| Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models | Q33571968 | ||
| Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci | Q33603097 | ||
| Can bacteria evolve resistance to quorum sensing disruption? | Q33632154 | ||
| Plasmid transfer in biofilms: a perspective on limitations and opportunities | Q33636216 | ||
| VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation | Q33677615 | ||
| Passive control of quorum sensing: prevention of Pseudomonas aeruginosa biofilm formation by imprinted polymers. | Q33832737 | ||
| Approaches to Dispersing Medical Biofilms | Q33845349 | ||
| Simplified AIP-II Peptidomimetics Are Potent Inhibitors of Staphylococcus aureus AgrC Quorum Sensing Receptors. | Q33894378 | ||
| Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection | Q33916479 | ||
| Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa | Q33944784 | ||
| Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus | Q33994610 | ||
| Functional microdomains in bacterial membranes | Q34102247 | ||
| Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors | Q34207135 | ||
| Growth dependence of conjugation explains limited plasmid invasion in biofilms: an individual-based modelling study | Q34215024 | ||
| Bacterial osmosensing: roles of membrane structure and electrostatics in lipid-protein and protein-protein interactions | Q34363946 | ||
| A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation | Q34379079 | ||
| Inhaled lactonase reduces Pseudomonas aeruginosa quorum sensing and mortality in rat pneumonia | Q34414546 | ||
| Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. | Q34439737 | ||
| MomL, a novel marine-derived N-acyl homoserine lactonase from Muricauda olearia | Q34448019 | ||
| Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway | Q34472793 | ||
| Structural and functional analysis of Bacillus subtilis YisP reveals a role of its product in biofilm production | Q34615108 | ||
| The hierarchy quorum sensing network in Pseudomonas aeruginosa | Q34864770 | ||
| Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient. | Q34908110 | ||
| Targeting virulence not viability in the search for future antibacterials. | Q35023691 | ||
| High-sensitivity monoclonal antibodies specific for homoserine lactones protect mice from lethal Pseudomonas aeruginosa infections | Q35031087 | ||
| Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials | Q35050042 | ||
| Pitfalls associated with evaluating enzymatic quorum quenching activity: the case of MomL and its effect on Pseudomonas aeruginosa and Acinetobacter baumannii biofilms | Q38809973 | ||
| Considerations and caveats in anti-virulence drug development | Q38810589 | ||
| Polypharmacology Approaches against the Pseudomonas aeruginosa MvfR Regulon and Their Application in Blocking Virulence and Antibiotic Tolerance | Q38852941 | ||
| Novel linear polymers able to inhibit bacterial quorum sensing. | Q38915890 | ||
| Presence of Biofilms on Polyurethane-Coated Breast Implants: Preliminary Results | Q38992333 | ||
| Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial Stewardship | Q39061539 | ||
| Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs | Q39173330 | ||
| Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance | Q39197564 | ||
| Bacterial Membranes: Structure, Domains, and Function | Q39429007 | ||
| Structure-based design and screen of novel inhibitors for class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae | Q39598025 | ||
| TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo | Q39617084 | ||
| The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung. | Q40062783 | ||
| Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting α-toxin expression | Q40133970 | ||
| Attenuating Staphylococcus aureus Virulence by Targeting Flotillin Protein Scaffold Activity | Q40150336 | ||
| In Situ Capture of Bacterial Toxins for Antivirulence Vaccination | Q40155457 | ||
| Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections. | Q40175211 | ||
| CRISPR Interference (CRISPRi) Inhibition of luxS Gene Expression in E. coli: An Approach to Inhibit Biofilm | Q40176863 | ||
| In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor Treatment | Q40179538 | ||
| Glyceryl trinitrate is a novel inhibitor of quorum sensing in Pseudomonas aeruginosa. | Q40223046 | ||
| Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection | Q40226804 | ||
| Mycobacterium abscessus subsp. abscessus Is Capable of Degrading Pseudomonas aeruginosa Quinolone Signals | Q40288402 | ||
| Staphylococcus aureus Survives in Cystic Fibrosis Macrophages, Forming a Reservoir for Chronic Pneumonia | Q40295903 | ||
| Biofilm formation of Achromobacter xylosoxidans on contact lens. | Q40325689 | ||
| CRISPR-based genome editing of clinically important Escherichia coli SE15 isolated from indwelling urinary catheters of patients | Q40411788 | ||
| Penicillin V acylases from gram-negative bacteria degrade N-acylhomoserine lactones and attenuate virulence in Pseudomonas aeruginosa | Q40417008 | ||
| Development of a novel series of non-natural triaryl agonists and antagonists of the Pseudomonas aeruginosa LasR quorum sensing receptor. | Q40459509 | ||
| Antisense locked nucleic acids targeting agrA inhibit quorum sensing and pathogenesis of community-associated methicillin-resistant Staphylococcus aureus | Q40513076 | ||
| Sclareol protects Staphylococcus aureus-induced lung cell injury via inhibiting alpha-hemolysin expression | Q40528066 | ||
| IVIG-mediated protection against necrotizing pneumonia caused by MRSA. | Q40531502 | ||
| 1,2,3-Triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation | Q40534514 | ||
| Truncated Autoinducing Peptides as Antagonists of Staphylococcus lugdunensis Quorum Sensing | Q40554825 | ||
| Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo | Q40556314 | ||
| Host Responses to Biofilm. | Q40559785 | ||
| Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections | Q40761003 | ||
| Application of Dual Inhibition Concept within Looped Autoregulatory Systems toward Antivirulence Agents against Pseudomonas aeruginosa Infections | Q40789654 | ||
| Inhibitory effects of antibiofilm compound 1 against Staphylococcus aureus biofilms. | Q40826464 | ||
| Hybrids of acylated homoserine lactone and nitric oxide donors as inhibitors of quorum sensing and virulence factors in Pseudomonas aeruginosa. | Q41047554 | ||
| Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification | Q41100882 | ||
| Design, synthesis and biological evaluation of 4-(alkyloxy)-6-methyl-2H-pyran-2-one derivatives as quorum sensing inhibitors | Q41180969 | ||
| High variability in quorum quenching and growth inhibition by furanone C-30 in Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients | Q41181052 | ||
| Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa | Q41334326 | ||
| Chalcone Attenuates Staphylococcus aureus Virulence by Targeting Sortase A and Alpha-Hemolysin. | Q41400482 | ||
| Zingerone silences quorum sensing and attenuates virulence of Pseudomonas aeruginosa | Q41470499 | ||
| Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD. | Q41641534 | ||
| Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice | Q41681261 | ||
| Regulation of bacteria population behaviors by AI-2 "consumer cells" and "supplier cells". | Q41712005 | ||
| Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii | Q41771875 | ||
| Biosynthesis of Squalene from Farnesyl Diphosphate in Bacteria: Three Steps Catalyzed by Three Enzymes | Q41871541 | ||
| Rhodococcus erythropolis BG43 Genes Mediating Pseudomonas aeruginosa Quinolone Signal Degradation and Virulence Factor Attenuation | Q41908511 | ||
| Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients | Q41919523 | ||
| Bacterial toxins: Offensive, defensive, or something else altogether? | Q41995627 | ||
| Quorum-quenching acylase reduces the virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans infection model | Q42111522 | ||
| Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by Staphylococcus aureus. | Q42638883 | ||
| Aii810, a Novel Cold-Adapted N-Acylhomoserine Lactonase Discovered in a Metagenome, Can Strongly Attenuate Pseudomonas aeruginosa Virulence Factors and Biofilm Formation | Q42654254 | ||
| Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies | Q42697422 | ||
| Attenuation of Vibrio fischeri quorum sensing using rationally designed polymers | Q43129549 | ||
| Dioxygenase-mediated quenching of quinolone-dependent quorum sensing in Pseudomonas aeruginosa. | Q43197650 | ||
| Cross species quorum quenching using a native AI-2 processing enzyme | Q43213175 | ||
| Resistance to the quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil in Pseudomonas aeruginosa clinical isolates. | Q43682863 | ||
| Synthesis and stability of small molecule probes for Pseudomonas aeruginosa quorum sensing modulation | Q45144916 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| infectious disease | Q18123741 | ||
| antibiotic | Q12187 | ||
| biofilm | Q467410 | ||
| quorum sensing | Q905754 | ||
| virulence | Q1460232 | ||
| membrane microdomain | Q22327677 | ||
| P304 | page(s) | 74 | |
| P577 | publication date | 2019-04-02 | |
| P1433 | published in | Frontiers in Cellular and Infection Microbiology | Q27724376 |
| P1476 | title | Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition | |
| P478 | volume | 9 |
| Q89620911 | Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates? |
| Q92541418 | Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections |
| Q89837655 | Definition of an α/β-hydrolase fold subfamily comprising Pseudomonas quinolone signal cleaving dioxygenases |
| Q92537820 | Explication of the Potential of 2-Hydroxy-4-Methoxybenzaldehyde in Hampering Uropathogenic Proteus mirabilis Crystalline Biofilm and Virulence |
| Q96303551 | Membrane-Interactive Compounds From Pistacia lentiscus L. Thwart Pseudomonas aeruginosa Virulence |
| Q99614361 | Microbiome dynamics and genomic determinants of bovine mastitis |
| Q104071613 | Tackling Pseudomonas aeruginosa Virulence by Mulinane-Like Diterpenoids from Azorella atacamensis |
| Q92152557 | The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors |
| Q91345378 | The global preclinical antibacterial pipeline |
Search more.